Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Carolyn Chatterton, Roberto Romero, Eunjung Jung, Dahiana M. Gallo, Manaphat Suksai, Ramiro Diaz-Primera, Offer Erez, Piya Chaemsaithong, Adi L. Tarca, Francesca Gotsch, Mariachiara Bosco & Tinnakorn Chaiworapongsa. (2023) A biomarker for bacteremia in pregnant women with acute pyelonephritis: soluble suppressor of tumorigenicity 2 or sST2. The Journal of Maternal-Fetal & Neonatal Medicine 36:1.
Read now
Read now
Angela J Okragly, Katie Brannon Corwin, Marikka Elia, Dongmei He, Oliver Schroeder, Qing Zhang, Tatiyana Shiyanova, Stuart Bright, Sarah B Dicker, Lukasz Chlewicki, Stephanie M E Truhlar, Julian Davies, Chetan N Patel & Robert J Benschop. (2021) Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33. Journal of Inflammation Research 14, pages 3823-3835.
Read now
Read now
Shenxia Gao & Junpu Li. (2020) Development of a Novel Homogeneous Nanoparticle-Based Assay for Rapid and High-Throughput Quantitation of the sST2 Protein in Human Serum. International Journal of Nanomedicine 15, pages 10539-10546.
Read now
Read now
Steffen D. Kriechbaum, Christoph B. Wiedenroth, Karina Peters, Marta A. Barde, Ruth Ajnwojner, Jan-Sebastian Wolter, Moritz Haas, Fritz C. Roller, Stefan Guth, Andreas J. Rieth, Andreas Rolf, Christian W. Hamm, Eckhard Mayer, Till Keller & Christoph Liebetrau. (2020) Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary hypertension. Biomarkers 25:7, pages 578-586.
Read now
Read now
Donatella Caserta, Luisa Di Benedetto, Giulia Bordi, Angelo D’Ambrosio & Massimo Moscarini. (2014) Levels of Galectin-3 and Stimulation Expressed Gene 2 in the peritoneal fluid of women with endometriosis: a pilot study. Gynecological Endocrinology 30:12, pages 877-880.
Read now
Read now
Giuseppe Lippi & Gianfranco Cervellin. (2014) Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers. Critical Reviews in Clinical Laboratory Sciences 51:1, pages 13-29.
Read now
Read now
Articles from other publishers (61)
Ankit Gupta, Roshan Mathew, Anjali Anand, Tanu Bhardwaj, Aakriti Singh, Krishna Singh, Amit Kumar, Prakash Ranjan Mishra & Tarun Kumar Sharma. (2024) A DNA aptamer-based assay for the detection of soluble ST2, a prognostic biomarker for monitoring heart failure. International Journal of Biological Macromolecules 256, pages 128295.
Crossref
Crossref
Koohyar Ahmadzadeh, Shayan Roshdi Dizaji, Mohammad Balabandian, Hamzah Adel Ramawad & Mahmoud Yousefifard. (2023) Soluble Suppression of Tumorigenicity-2 as a Candidate Prognostic Marker for Stroke: A Systematic Review. Annals of Laboratory Medicine 43:6, pages 585-595.
Crossref
Crossref
Zhicheng Ye, Chuanshu Chen, Shiwei Chen, Menghua Xu & Jin Xu. (2023) Analytical performances of a new rapid assay of soluble ST2 for cardiac and inflammatory diseases and establishment of the reference intervals for children and adolescence in China. Practical Laboratory Medicine 36, pages e00321.
Crossref
Crossref
Murat Kerkütlüoğlu, Hakan Gunes, Nurhan Atilla, Enes Celik, Musa Dagli & Muhammed Seyithanoglu. (2023) Relationship Between Soluble ST2 Level and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Acute Pulmonary Embolism (PE) Patients. Cureus.
Crossref
Crossref
Chengcheng Shao, Yu Cao, Zengtao Wang, Xiaomeng Wang, Chenglong Li, Xing Hao, Liangshan Wang, Zhongtao Du, Feng Yang, Chunjing Jiang, Hong Wang, Yu Hao, Junyan Han & Xiaotong Hou. (2023) Soluble ST2 predicts continuous renal replacement therapy in patients receiving venoarterial extracorporeal membrane oxygenation. Perfusion, pages 026765912311694.
Crossref
Crossref
Haley N. Ferguson, Hugo R. Martinez, P. Melanie Pride, Elizabeth A. Swan, Roger A. Hurwitz & R. Mark Payne. (2023) Biomarker sST2 in Adults with Transposition of the Great Arteries Palliated by Mustard Procedure: A Five-Year Follow-up. Pediatric Cardiology 44:4, pages 927-932.
Crossref
Crossref
Marco Alfonso Perrone, Alberto Aimo, Sergio Bernardini & Aldo Clerico. (2023) Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers. International Journal of Molecular Sciences 24:1, pages 844.
Crossref
Crossref
Jinchao Chen, Peng Xiao, Dan Song, Dewei Song, Zhi Chen & Hongmei Li. (2022) Growth stimulation expressed gene 2 (ST2): Clinical research and application in the cardiovascular related diseases. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Huangshu Ye, Qianwen Wu, Ning Zhang, Jing Shi, Haifeng Zhang, Qiang Wang, Miaojia Zhang & Xiaoxuan Sun. (2022) The prognostic value of sST2 in connective tissue disease patients with pulmonary hypertension. Rheumatology 61:10, pages 3989-3996.
Crossref
Crossref
Marco Alfonso Perrone, Julien Favresse, Annamaria D’Alessandro, Federica Albanese, Coralie De Bruyne, Stefano Ceccarelli, Fabrizio Drago, Paolo Guccione, Ottavia Porzio & Benedetta Leonardi. (2022) Soluble Isoform of Suppression of Tumorigenicity 2 (ST2) Biomarker in a Large Cohort of Healthy Pediatric Population: Determination of Reference Intervals. Journal of Clinical Medicine 11:16, pages 4693.
Crossref
Crossref
Soloman Saleh, Jacob George, Katharine A. Kott, Peter J. Meikle & Gemma A. Figtree. (2022) The Translation and Commercialisation of Biomarkers for Cardiovascular Disease—A Review. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Giuseppe Vergaro, Alberto Aimo, James L. Januzzi, A. Mark Richards, Carolyn S.P. Lam, Roberto Latini, Lidia Staszewsky, Inder S. Anand, Thor Ueland, Hans-Peter Brunner-La Rocca, Antoni Bayes-Genis, Josep Lupón, Rudolf A. de Boer, Akiomi Yoshihisa, Yasuchika Takeishi, Ida Gustafsson, Kai M. Eggers, Kurt Huber, Greg D. Gamble, Kui Toh Gerard Leong, Poh Shuan Daniel Yeo, Hean Yee Ong, Fazlur Jaufeerally, Tze P. Ng, Richard Troughton, Robert N. Doughty, Michele Emdin & Claudio Passino. (2022) Cardiac biomarkers retain prognostic significance in patients with heart failure and chronic obstructive pulmonary disease. Journal of Cardiovascular Medicine 23:1, pages 28-36.
Crossref
Crossref
Christina Ip, King Sum Luk, Vincent Lok Cheung Yuen, Lorraine Chiang, Ching Ki Chan, Kevin Ho, Mengqi Gong, Teddy Tai Loy Lee, Keith Sai Kit Leung, Leonardo Roever, George Bazoukis, Konstantinos Lampropoulos, Ka Hou Christien Li, Gary Tse & Tong Liu. (2021) Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis. IJC Heart & Vasculature 37, pages 100887.
Crossref
Crossref
Elena Revuelta-López, Jaume Barallat, Adriana Cserkóová, Carolina Gálvez-Montón, Allan S. Jaffe, James L. Januzzi & Antoni Bayes-Genis. (2021) Pre-analytical considerations in biomarker research: focus on cardiovascular disease. Clinical Chemistry and Laboratory Medicine (CCLM) 59:11, pages 1747-1760.
Crossref
Crossref
Angela Pucci, Alberto Aimo, Veronica Musetti, Andrea Barison, Giuseppe Vergaro, Dario Genovesi, Assuero Giorgetti, Silvia Masotti, Chiara Arzilli, Concetta Prontera, Luigi Emilio Pastormerlo, Michele Alessandro Coceani, Marco Ciardetti, Nicola Martini, Cataldo Palmieri, Claudio Passino, Claudio Rapezzi & Michele Emdin. (2021) Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis. Journal of the American Heart Association 10:20.
Crossref
Crossref
Steffen D. Kriechbaum, Julia M. Vietheer, Christoph B. Wiedenroth, Felix Rudolph, Marta Barde, Jan‐Sebastian Wolter, Moritz Haas, Ulrich Fischer‐Rasokat, Maren Weferling, Andreas Rolf, Christian W. Hamm, Eckhard Mayer, Stefan Guth, Till Keller, Fritz C. Roller & Christoph Liebetrau. (2021) Cardiac biomarkers as indicators of right ventricular dysfunction and recovery in chronic thromboembolic pulmonary hypertension patients after balloon pulmonary angioplasty therapy – a cardiac magnetic resonance imaging cohort study. Pulmonary Circulation 11:4, pages 1-10.
Crossref
Crossref
Brenda Moura, Alberto Aimo, Abdallah Al‐Mohammad, Andreas Flammer, Vassilis Barberis, Antoni Bayes‐Genis, Hans‐Peter Brunner‐La Rocca, Ricardo Fontes‐Carvalho, Julia Grapsa, Martin Hülsmann, Nasrien Ibrahim, Christian Knackstedt, James L. Januzzi, Tomas Lapinskas, Axel Sarrias, Simon Matskeplishvili, Wouter C. Meijers, Daniel Messroghli, Christian Mueller, Noemi Pavo, Justas Simonavičius, Arco J. Teske, Roland Kimmenade, Petar Seferovic, Andrew J.S. Coats, Michele Emdin & A. Mark Richards. (2021) Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure 23:10, pages 1577-1596.
Crossref
Crossref
Luigi Marzio Biasucci, Alessandro Maino, Maria Chiara Grimaldi, Luigi Cappannoli & Nadia Aspromonte. (2021) Novel Biomarkers in Heart Failure: New Insight in Pathophysiology and Clinical Perspective. Journal of Clinical Medicine 10:13, pages 2771.
Crossref
Crossref
Marta Banaszkiewicz, Arkadiusz Pietrasik, Michał Florczyk, Piotr Kędzierski, Michał Piłka, Rafał Mańczak, Janusz Kochman, Grzegorz Opolski, Adam Torbicki, Marcin Kurzyna & Szymon Darocha. (2021) Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty. Diagnostics 11:1, pages 133.
Crossref
Crossref
N. G. Gumanova, M. V. Klimushina, N. L. Bogdanova, O. V. Stefanyuk & V. A. Metelskaya. (2020) Valid cardiac biochemical markers. Part II. Cardiovascular Therapy and Prevention 19:5, pages 2588.
Crossref
Crossref
Alberto Aimo, James L. JanuzziJrJr, Giuseppe Vergaro, A. Mark Richards, Carolyn S.P. Lam, Roberto Latini, Inder S. Anand, Jay N. Cohn, Thor Ueland, Lars Gullestad, Pål Aukrust, Hans‐Peter Brunner‐La Rocca, Antoni Bayes‐Genis, Josep Lupón, Rudolf A. Boer, Yasuchika Takeishi, Michael Egstrup, Ida Gustafsson, Hanna K. Gaggin, Kai M. Eggers, Kurt Huber, Greg D. Gamble, Lieng H. Ling, Kui Tong Gerard Leong, Poh Shuah Daniel Yeo, Hean Yee Ong, Fazlur Jaufeerally, Tze P. Ng, Richard Troughton, Robert N. Doughty, Claudio Passino & Michele Emdin. (2020) Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T. European Journal of Heart Failure 22:11, pages 2078-2088.
Crossref
Crossref
Justin Sharim & Lori B. Daniels. (2020) Soluble ST2 and Soluble Markers of Fibrosis: Emerging Roles for Prognosis and Guiding Therapy. Current Cardiology Reports 22:6.
Crossref
Crossref
Reza S. Pratama, Anggoro B. Hartopo, Dyah W. Anggrahini, Vera C. Dewanto & Lucia K. Dinarti. (2020) Serum soluble suppression of tumorigenicity‐2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect. Pulmonary Circulation 10:2, pages 1-8.
Crossref
Crossref
Fulvio Morello, Alice Bartalucci, Marco Bironzo, Marco Santoro, Emanuele Pivetta, Alice Ianniello, Francesca Rumbolo, Giulio Mengozzi & Enrico Lupia. (2020) Prospective diagnostic accuracy study of plasma soluble ST2 for diagnosis of acute aortic syndromes. Scientific Reports 10:1.
Crossref
Crossref
Pei-Hsun Sung, Hung Sheng Lin, Kuan-Hung Chen, John Y. Chiang, Sheung-Fat Ko, Pei-Lin Shao, Hsin-Ju Chiang, Chi-Hsiang Chu, Yi-Chen Li, Han-Tan Chai, Kun-Chen Lin & Hon-Kan Yip. (2020) Soluble ST2 is a Useful Biomarker for Grading Cerebral–Cardiac Syndrome in Patients after Acute Ischemic Stroke. Journal of Clinical Medicine 9:2, pages 489.
Crossref
Crossref
Dipal M. Patel, Heather Thiessen-Philbrook, Jeremiah R. Brown, Eric McArthur, Dennis G. Moledina, Sherry G. Mansour, Michael G. Shlipak, Jay L. Koyner, Peter Kavsak, Richard P. Whitlock, Allen D. Everett, David J. Malenka, Amit X. Garg, Steven G. Coca & Chirag R. Parikh. (2020) Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery. American Heart Journal 220, pages 253-263.
Crossref
Crossref
Iryna Mezhiievska, Valerii Ivanov & Valentyn Maslovskyi. (2020) ST2 PLASMA LEVEL IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT ST ELEVATION AND DIFFERENT CLINICAL CHARACTERISTICS. EUREKA: Health Sciences 1, pages 47-54.
Crossref
Crossref
Alberto Aimo, James L JanuzziJrJr, Giuseppe Vergaro, Aldo Clerico, Roberto Latini, Jennifer Meessen, Inder S Anand, Jay N Cohn, Jørgen Gravning, Thor Ueland, Ståle H Nymo, Hans-Peter Brunner-La Rocca, Antoni Bayes-Genis, Josep Lupón, Rudolf A de Boer, Akiomi Yoshihisa, Yasuchika Takeishi, Michael Egstrup, Ida Gustafsson, Hanna K Gaggin, Kai M Eggers, Kurt Huber, Ioannis Tentzeris, Andrea Ripoli, Claudio Passino & Michele Emdin. (2019) Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome. European Journal of Preventive Cardiology 26:16, pages 1751-1759.
Crossref
Crossref
Alberto Aimo, James L. JanuzziJr.Jr., Antoni Bayes-Genis, Giuseppe Vergaro, Paolo Sciarrone, Claudio Passino & Michele Emdin. (2019) Clinical and Prognostic Significance of sST2 in Heart Failure. Journal of the American College of Cardiology 74:17, pages 2193-2203.
Crossref
Crossref
Linlin Gu & Jing Li. (2019) Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis. Bioscience Reports 39:6.
Crossref
Crossref
M. Wesley Milks & Vijay Nambi. 2019. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease
81
96
.
Stefan Hacker, Benjamin Dieplinger, Gregor Werba, Stefanie Nickl, Georg A. Roth, Claus G. Krenn, Thomas Mueller, Hendrik J. Ankersmit & Thomas Haider. (2018) Increased serum concentrations of soluble ST2 predict mortality after burn injury. Clinical Chemistry and Laboratory Medicine (CCLM) 56:12, pages 2079-2087.
Crossref
Crossref
Liya Li, Honglin Zhu & Xiaoxia Zuo. (2018) Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis. Frontiers in Immunology 9.
Crossref
Crossref
Michele Emdin, Alberto Aimo, Giuseppe Vergaro, Antoni Bayes-Genis, Josep Lupón, Roberto Latini, Jennifer Meessen, Inder S. Anand, Jay N. Cohn, Jørgen Gravning, Lars Gullestad, Kaspar Broch, Thor Ueland, Ståle H. Nymo, Hans-Peter Brunner-La Rocca, Rudolf A. de Boer, Hanna K. Gaggin, Andrea Ripoli, Claudio Passino & James L. JanuzziJr.Jr.. (2018) sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T. Journal of the American College of Cardiology 72:19, pages 2309-2320.
Crossref
Crossref
Jamshed J. Dalal, Aarti Digrajkar, Barnali Das, Manish Bansal, Avinash Toomu & Alan S. Maisel. (2018) ST2 elevation in heart failure, predictive of a high early mortality. Indian Heart Journal 70:6, pages 822-827.
Crossref
Crossref
A. T. Teplyakov, N. I. Tarasov, L. K. Isakov, E. V. Grakova, M. N. Sinkova, K. V. Kopieva, О. B. Garmaeva, O. N. Ogurkova, V. V. Kalyuzhin & E. V. Kalyuzhina. (2018) Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma. Bulletin of Siberian Medicine 17:3, pages 140-150.
Crossref
Crossref
Hee-Won MoonMikyoung ParkMina HurHanah KimWon Hyeok ChoeYeo-Min Yun. (2018) Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases. Annals of Laboratory Medicine 38:4, pages 331.
Crossref
Crossref
Hyun Suk YangMina HurAhram YiHanah KimJayoun Kim. (2018) Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery. Annals of Laboratory Medicine 38:3, pages 204.
Crossref
Crossref
Hanah Kim, Mina Hur, Hee-Won Moon, Yeo-Min Yun & Salvatore Di Somma. (2017) Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. Annals of Intensive Care 7:1.
Crossref
Crossref
Anja Stundl, Nina-Sophie Lünstedt, Florian Courtz, Sandra Freitag-Wolf, Norbert Frey, Stefan Holdenrieder, Berndt Zur, Eberhard Grube, Georg Nickenig, Nikos Werner, Derk Frank & Jan-Malte Sinning. (2017) Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation. The American Journal of Cardiology 120:6, pages 986-993.
Crossref
Crossref
Dario Grande, Marta Leone, Caterina Rizzo, Paola Terlizzese, Giuseppe Parisi, Margherita Gioia, Tiziana Leopizzi, Antonio Segreto, Piero Guida, Roberta Romito, Marco Ciccone, Francesca Serio & Massimo Iacoviello. (2017) A Multiparametric Approach Based on NT-proBNP, ST2, and Galectin3 for Stratifying One Year Prognosis of Chronic Heart Failure Outpatients. Journal of Cardiovascular Development and Disease 4:3, pages 0009.
Crossref
Crossref
Usman Mahmood, David W. Johnson & Magid A. Fahim. (2021) Cardiac biomarkers in dialysis. AIMS Genetics 04:01, pages 001-020.
Crossref
Crossref
Alberto Aimo, Giuseppe Vergaro, Claudio Passino, Andrea Ripoli, Bonnie Ky, Wayne L. Miller, Antoni Bayes-Genis, Inder Anand, James L. Januzzi & Michele Emdin. (2017) Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure. JACC: Heart Failure 5:4, pages 280-286.
Crossref
Crossref
Hanah KimJi Myung KimMina HurMi-Kyung ParkHee-Won MoonYeo-Min YunHan Sung HwangHan Sung KwonIn Sook SohnMina Lee on behalf of GREAT Network. (2016) Distribution of soluble suppression of tumorigenicity 2 (sST2), N-terminal pro-brain natriuretic peptide (NT-proBNP), high sensitive troponin I and high-sensitive troponin T in umbilical cord blood. Clinical Chemistry and Laboratory Medicine (CCLM) 54:11, pages 1793-1798.
Crossref
Crossref
Antoni Bayes-Genis, Julio N??ez, Eduardo N??ez, Jaume Barallat Mart?nez, Maria-Cruz Pastor Ferrer, Marta de Antonio, Elisabet Zamora, Juan Sanchis & Josep Lup?n Ros?s. (2016) Multi-Biomarker Profiling and Recurrent Hospitalizations in Heart Failure. Frontiers in Cardiovascular Medicine 3.
Crossref
Crossref
Robert Chen. (2016) Clinical roles of soluble ST2 for the outcomes of cardiac valve operations. Research Ideas and Outcomes 2, pages e8849.
Crossref
Crossref
Chiara Caselli, Rosetta Ragusa, Concetta Prontera, Manuela Cabiati, Massimiliano Cantinotti, Giovanni Federico, Silvia Del Ry, Maria Giovanna Trivella & Aldo Clerico. (2016) Distribution of circulating cardiac biomarkers in healthy children: from birth through adulthood. Biomarkers in Medicine 10:4, pages 357-365.
Crossref
Crossref
Hyun Suk YangMina HurHanah KimLaura MagriniRossella MarinoSalvatore Di Somma. (2016) Soluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis. Annals of Laboratory Medicine 36:6, pages 590.
Crossref
Crossref
Domingo A. Pascual-Figal, Antonio Lax, Maria Teresa Perez-Martinez, Maria del Carmen Asensio-Lopez, Jesus Sanchez-Mas & on behalf of GREAT Network. (2016) Clinical relevance of sST2 in cardiac diseases. Clinical Chemistry and Laboratory Medicine (CCLM) 54:1.
Crossref
Crossref
A. Rogier van der Velde, Chris P.H. Lexis, Wouter C. Meijers, Iwan C. van der Horst, Erik Lipsic, Martin M. Dokter, Dirk J. van Veldhuisen, Pim van der Harst & Rudolf A. de Boer. (2016) Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction. Clinica Chimica Acta 452, pages 50-57.
Crossref
Crossref
Benjamin Dieplinger, Margot Egger, Alfons Gegenhuber, Meinhard Haltmayer & Thomas Mueller. (2015) Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasma. Clinica Chimica Acta 451, pages 310-315.
Crossref
Crossref
Yi Wang, Wei Wang, Lina Yu, Liang Tu, Yinglong Feng, Todd Klein & Jian-Ping Wang. (2015) Giant magnetoresistive-based biosensing probe station system for multiplex protein assays. Biosensors and Bioelectronics 70, pages 61-68.
Crossref
Crossref
James L. Januzzi, Alexandre Mebazaa & Salvatore Di Somma. (2015) ST2 and Prognosis in Acutely Decompensated Heart Failure: The International ST2 Consensus Panel. The American Journal of Cardiology 115:7, pages 26B-31B.
Crossref
Crossref
Thomas Mueller & Allan S. Jaffe. (2015) Soluble ST2—Analytical Considerations. The American Journal of Cardiology 115:7, pages 8B-21B.
Crossref
Crossref
Benjamin Dieplinger & Thomas Mueller. (2015) Soluble ST2 in heart failure. Clinica Chimica Acta 443, pages 57-70.
Crossref
Crossref
Peter A. McCullough & John L. Jefferies. (2015) Novel Markers and Therapies for Patients with Acute Heart Failure and Renal Dysfunction. The American Journal of Medicine 128:3, pages 312.e1-312.e22.
Crossref
Crossref
Mina HurHanah KimHyun Jeong KimHyun Suk YangLaura MagriniRossella MarinoPatrizia CardelliSalvatore Di Somma. (2015) Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis. Annals of Laboratory Medicine 35:6, pages 570.
Crossref
Crossref
Ya-Guo Zheng, Tao Yang, Jian-Guo He, Guo Chen, Zhi-Hong Liu, Chang-Ming Xiong, Qing Gu, Xin-Hai Ni & Zhi-Hui Zhao. (2014) Plasma Soluble ST2 Levels Correlate With Disease Severity and Predict Clinical Worsening in Patients With Pulmonary Arterial Hypertension. Clinical Cardiology 37:6, pages 365-370.
Crossref
Crossref
Benjamin Dieplinger, Margot Egger, Meinhard Haltmayer, Marcus E Kleber, Hubert Scharnagl, Guenther Silbernagel, Rudolf A de Boer, Winfried Maerz & Thomas Mueller. (2014) Increased Soluble ST2 Predicts Long-term Mortality in Patients with Stable Coronary Artery Disease: Results from the Ludwigshafen Risk and Cardiovascular Health Study. Clinical Chemistry 60:3, pages 530-540.
Crossref
Crossref
Damien Gruson, Thibault Lepoutre, Sylvie A. Ahn & Michel F. Rousseau. (2014) Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction. International Journal of Cardiology 172:1, pages e250-e252.
Crossref
Crossref
Cristina Pop, Gianina C. Crişan, Felicia Loghin & Cristina I. Mogoşan. (2013) Advances in the detection and quantification of candidate and established biomarkers in heart failure. Romanian Review of Laboratory Medicine 21:3.
Crossref
Crossref